ADHA exec Mark Kinsela appointed CEO of PSA

Australian Digital Health Agency chief of staff Mark Kinsela has been appointment the new CEO of the Pharmaceutical Society of Australia (PSA), taking over from acting CEO Shane Jackson.

Mr Kinsela, who trained as an intensive care nurse and clinical nurse educator, has also been an adviser to federal health and aged care ministers.

PSA national president Chris Freeman said Mr Kinsela's career has taken in all aspects of health care, from delivery through to policy, and had given him an exceptional level of expertise and insight into the challenges facing Australia’s healthcare systems and potential solutions.

“We believe Mark’s training as a healthcare provider and executive MBA, combined with his impressive professional background, will help PSA continue to ensure our profession has the opportunity to positively contribute to policy making at the highest levels and achieve the goals outlined in our Pharmacists in 2023 vision,” Associate Professor Freeman said.

Dr Jackson, a previous national president who has been acting in CEO role while the association looked for a new CEO, will continue to lead the PSA's negotiations for the 7CPA, A/Prof Freeman said.

Mr Kinsela will begin his new role on December 2.

Posted in Movers and shakers

Tags: ADHA, Pharmaceutical Society of Australia

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit